MedPath

COVID-19 Personal Protective Equipment for Vaccinated Health Workers and Convalescents

Withdrawn
Conditions
Covid19
Interventions
Other: Personal Protective Equipment
Registration Number
NCT06158724
Lead Sponsor
University Medical Centre Ljubljana
Brief Summary

The aim of the trial is to assess the safety of using simplified personal protective equipment (PPE) for vaccinated or COVID-19 convalescent healthcare workers working in COVID-19 ICU or COVID-19 wards.

The trial is designed as a prospective randomized observational trial with volunteer medical staff working in COVID-19 departments aiming to show non-inferiority of simplified PPE vs standard COVID-19 PPE.

Detailed Description

Objectives To assess safety of simplified personal protective equipment (PPE) for vaccinated health workers and COVID-19 convalescents - pilot trial.

Methods Prospective randomized observational trial. 60 participants randomized 1:1 to either standard PPE (COVID-19 ward: FFP2 or higher respirator, goggles of face shield, gown, gloves; COVID-19 ICU: FFP3 respirator and tight goggles or full face mask or powered air-purifying respirators, gown and gloves) or simplified PPE (surgical mask, goggles or face shield, gown). 30 days follow up period.

Participants Volunteer medical staff from COVID-19 regular and ICU departments at University Medical Center Ljubljana, Slovenia, with either proven COVID-19 infection within 6 months or at least 7 days after second dose anti COIVD-19 vaccine.

Hypotheses Simplified PPE is non-inferior to standard PPE in vaccinated health workers or convalescents.

Discussion Positive study results may decrease PPE spending cost and positively affect working conditions at COVID-19 departments.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • age < 50 years
  • prior COVID-19 infection; time from infection < 6 months.
  • prior completed anti COVID-19 immunization; > 1 week post second dose of immunization.
  • signed written consent
  • negative nasopharyngeal COVID-19 RT-PCR test
Read More
Exclusion Criteria
  • age > 50 years
  • time post COVID-19 infection > 6 months
  • time post COVID-19 immunization < 1 week.
  • immunocompromised patients
  • pregnancy
  • CKD 3 or more
  • COPD or other lung disease
  • heart failure of any cause
  • ischemic heart disease
  • obesity (BMI > 30)
  • DM on therapy
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Simplified PPE groupPersonal Protective EquipmentSurgical mask, standard non sealing goggles, use of protective gown while in direct contact with patients.
Primary Outcome Measures
NameTimeMethod
Non-inferiority of simplified PPE compared to standard PPE regarding symptomatic infection rate.30 days

The use of simplified PPE will not predispose COVID-19 immune healthcare workers to symptomatic neoinfection.

Secondary Outcome Measures
NameTimeMethod
Non-inferiority of simplified PPE compared to standard PPE regarding asymptomatic infection rate.30 days

No difference in nasopharyngeal RT-PCR SARS-CoV 2 results between groups.

Rise in anti-SARS-CoV 2 antibody titers in the simplified PPE group.30 days

Trial Locations

Locations (1)

University Medical Center Ljubljana

🇸🇮

Ljubljana, Slovenia

© Copyright 2025. All Rights Reserved by MedPath